• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药停药症状的管理综述。

A review of the management of antidepressant discontinuation symptoms.

作者信息

Wilson Emma, Lader Malcolm

机构信息

King's College London, Institute of Psychiatry, London SE5 8AF, UK.

King's College London, London, UK.

出版信息

Ther Adv Psychopharmacol. 2015 Dec;5(6):357-68. doi: 10.1177/2045125315612334.

DOI:10.1177/2045125315612334
PMID:26834969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4722507/
Abstract

Strong evidence supports the existence of a discontinuation syndrome following the withdrawal of antidepressant medication, particularly second-generation antidepressants. The syndrome is a common phenomenon and guidance as to best avoid the symptoms is essential for both practitioners and patients. The current study reviewed the available literature on the best methods of discontinuation for antidepressants in order to avoid or prevent the occurrence of any unpleasant side effects associated with antidepressant withdrawal. Accordingly, an electronic search of the PubMed/MedLine database and Google Scholar was conducted to find relevant literature published within the last 10 years. From this, 18 related articles were identified; five clinical studies, one case series, one consensus panel's recommendations and 11 literature reviews. Of the articles reviewed there is a general consensus as to tapering the drug slowly over a period of weeks or months. Also, in those patients who experience severe symptoms the drug should be reinstated and discontinued more gradually. The discontinuation syndrome does not occur as frequently or severely with longer-acting agents such as fluoxetine and therefore it is recommended that switching to this drug prior to withdrawal may be advisable. The articles reviewed also emphasize the need for patient education and reassurance throughout the discontinuation process. One in particular adds that cognitive behavioural therapy may be a useful tool in easing the patients' distress. However, this review highlights the lack of controlled data to support the available guidelines. Furthermore, the guidance which is available is somewhat conflicting. Research approaches should address this issue as well as develop appropriate methods of withdrawal for specific drugs.

摘要

有力证据支持在停用抗抑郁药物后,尤其是第二代抗抑郁药物后,会出现停药综合征。该综合征是一种常见现象,对于从业者和患者而言,了解如何最好地避免这些症状至关重要。本研究回顾了关于抗抑郁药物最佳停药方法的现有文献,以避免或预防与抗抑郁药物撤药相关的任何不良副作用的发生。因此,对PubMed/MedLine数据库和谷歌学术进行了电子检索,以查找过去10年内发表的相关文献。从中确定了18篇相关文章;5项临床研究、1个病例系列、1个共识小组的建议和11篇文献综述。在所审查的文章中,对于在数周或数月的时间内缓慢减药存在普遍共识。此外,对于那些出现严重症状的患者,应恢复用药并更缓慢地停药。与氟西汀等长效药物相比,停药综合征的发生频率和严重程度较低,因此建议在撤药前换用这种药物可能是明智的。所审查的文章还强调在整个停药过程中需要对患者进行教育和安抚。特别是有一篇文章补充说,认知行为疗法可能是缓解患者痛苦的有用工具。然而,本综述强调缺乏支持现有指南的对照数据。此外,现有的指南也存在一定冲突。研究方法应解决这一问题,并为特定药物制定合适的撤药方法。

相似文献

1
A review of the management of antidepressant discontinuation symptoms.抗抑郁药停药症状的管理综述。
Ther Adv Psychopharmacol. 2015 Dec;5(6):357-68. doi: 10.1177/2045125315612334.
2
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.抗抑郁药停药综合征:临床管理与进一步研究的共识小组建议
J Clin Psychiatry. 2006;67 Suppl 4:27-30.
3
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review.关于抑郁症患者减停抗抑郁药物的临床实践指南建议:一项系统评价
Ther Adv Psychopharmacol. 2022 Feb 11;12:20451253211067656. doi: 10.1177/20451253211067656. eCollection 2022.
4
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.SSRIs 停药后出现的戒断症状:系统评价。
Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17.
5
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.选择性5-羟色胺再摄取抑制剂停药后的戒断症状:一项系统评价
Psychother Psychosom. 2015;84(2):72-81. doi: 10.1159/000370338. Epub 2015 Feb 21.
6
Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years.使用逐渐减量药条停药1至5年后抗抑郁药物的停药结果。
Ther Adv Psychopharmacol. 2020 Sep 2;10:2045125320954609. doi: 10.1177/2045125320954609. eCollection 2020.
7
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need.为抗抑郁药使用者设计戒断支持服务:患者对现有服务的看法及他们真正的需求。
J Psychiatr Res. 2023 May;161:298-306. doi: 10.1016/j.jpsychires.2023.03.013. Epub 2023 Mar 20.
8
Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial.由监测加正念认知疗法支持的初级保健中抗抑郁药物停药与单独监测的比较:一项集群随机对照试验的设计和方案。
BMC Fam Pract. 2019 Jul 26;20(1):105. doi: 10.1186/s12875-019-0989-5.
9
10
Antidepressant discontinuation syndrome.抗抑郁药停药综合征
Am Fam Physician. 2006 Aug 1;74(3):449-56.

引用本文的文献

1
Fluoxetine substitution for deprescribing antidepressants: a technical approach.用氟西汀替代减停抗抑郁药:一种技术方法。
J Psychiatry Neurosci. 2025 Jul 3;50(4):E202-E209. doi: 10.1503/jpn.250054. Print 2025 Jul-Aug.
2
Do withdrawal symptoms predict depression relapse after antidepressant cessation?戒断症状能否预测抗抑郁药停药后的抑郁症复发?
Eur Arch Psychiatry Clin Neurosci. 2025 Apr 23. doi: 10.1007/s00406-025-02005-z.
3
From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy.从证据到实践:合成抗抑郁药治疗副作用的综合分析
Curr Drug Saf. 2025;20(2):120-147. doi: 10.2174/0115748863301630240417071353.
4
A Retrospective Case-Control Study on the Differences in the Effectiveness of Theta-Burst Stimulation Therapy for Depression with and without Antidepressant Medication.一项关于有无抗抑郁药物治疗的抑郁症患者经颅磁刺激治疗效果差异的回顾性病例对照研究
J Clin Med. 2024 Jan 11;13(2):399. doi: 10.3390/jcm13020399.
5
Depression and Its Phytopharmacotherapy-A Narrative Review.抑郁及其植物药治疗——一个叙述性综述。
Int J Mol Sci. 2023 Mar 1;24(5):4772. doi: 10.3390/ijms24054772.
6
Availability of two essential medicines for mental health in Bangladesh, the Democratic Republic of Congo, Haiti, Nepal, Malawi, Senegal, and Tanzania: Evidence from nationally representative samples of 7958 health facilities.孟加拉国、刚果民主共和国、海地、尼泊尔、马拉维、塞内加尔和坦桑尼亚 7958 家卫生机构的全国代表性样本显示,这两个基本精神卫生药物在这些国家的供应情况。
J Glob Health. 2022 Aug 1;12:04063. doi: 10.7189/jogh.12.04063.
7
Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19:安全性与预防分析。
Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.
8
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.成人抑郁和焦虑障碍中长效抗抑郁药停药与继续使用的方法。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
9
Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.停用抗抑郁药后的迁延性戒断综合征:来自一个大型网络论坛的消费者叙述的描述性定量分析
Ther Adv Psychopharmacol. 2020 Dec 24;10:2045125320980573. doi: 10.1177/2045125320980573. eCollection 2020.
10
The Xyrem (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017.美国羟丁酸钠(Xyrem)风险评估与缓解策略(REMS)项目:2016年至2017年的结果
Drugs Real World Outcomes. 2021 Mar;8(1):15-28. doi: 10.1007/s40801-020-00223-6. Epub 2021 Jan 13.

本文引用的文献

1
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.使用抗抑郁药治疗抑郁症的循证指南:2008年英国精神药理学会指南的修订版
J Psychopharmacol. 2015 May;29(5):459-525. doi: 10.1177/0269881115581093. Epub 2015 May 12.
2
[Taperingstrips for paroxetine and venlafaxine].[帕罗西汀和文拉法辛的逐渐减量方案]
Tijdschr Psychiatr. 2013;55(10):789-94.
3
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.苯二氮䓬类药物与抗抑郁药治疗焦虑障碍的疗效和耐受性:系统评价和荟萃分析。
Psychother Psychosom. 2013;82(6):355-62. doi: 10.1159/000353198. Epub 2013 Sep 20.
4
Agomelatine in depression.阿戈美拉汀治疗抑郁症。
Expert Opin Drug Saf. 2013 Nov;12(6):873-80. doi: 10.1517/14740338.2013.828690. Epub 2013 Sep 16.
5
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.选择性 5-羟色胺再摄取抑制剂抗抑郁药停药综合征:临床证据及可能涉及的机制综述。
Front Pharmacol. 2013 Apr 16;4:45. doi: 10.3389/fphar.2013.00045. eCollection 2013.
6
Guidance for the discontinuation or switching of antidepressant therapies in adults.成人抗抑郁治疗停药或换药指南。
J Pharm Pract. 2013 Aug;26(4):389-96. doi: 10.1177/0897190012467210. Epub 2013 Mar 4.
7
Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain.西班牙初级护理护士管理的苯二氮䓬类药物戒断计划分析。
BMC Res Notes. 2012 Dec 13;5:684. doi: 10.1186/1756-0500-5-684.
8
Tapering antidepressants: is 3 months slow enough?逐渐减少抗抑郁药剂量:3 个月够慢吗?
Med Hypotheses. 2011 Dec;77(6):1006-8. doi: 10.1016/j.mehy.2011.08.035. Epub 2011 Sep 14.
9
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.治疗重度抑郁症的安全性监测指南的共识声明。
Aust N Z J Psychiatry. 2011 Sep;45(9):712-25. doi: 10.3109/00048674.2011.595686.
10
Adverse reactions to duloxetine in depression.度洛西汀治疗抑郁症的不良反应。
Expert Opin Drug Saf. 2011 Nov;10(6):839-50. doi: 10.1517/14740338.2011.582037. Epub 2011 May 5.